Skip to main content

Table 5 Newborn characteristics

From: Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women

 

Korean subgroup (mean ± SD)

Non-Korean subgroup (mean ± SD)

FCM (N = 45)

FS (N = 44)

FCM (N = 78)

FS (N = 80)

Birthweight, kg

3.2 ± 0.4

3.2 ± 0.4

3.5 ± 0.5

3.5 ± 0.5

Birth length, cm

49.6 ± 2.4

49.4 ± 2.5

51.6 ± 2.5

51.5 ± 2.9

Cord hemoglobin, g/dL

14.9 ± 1.2

15.0 ± 1.3

14.7 ± 2.8

14.0 ± 2.0

Cord hematocrit, ratio

0.5 ± 0.1

0.5 ± 0.1

0.5 ± 0.1

0.5 ± 0.1

Cord serum ferritin, μg/L

269 ± 139

227 ± 117

242 ± 225

248 ± 155

1-min Apgar

9.5 ± 0.8

9.0 ± 1.4

8.2 ± 0.7

8.1 ± 1.3

5-min Apgar

9.4 ± 0.6

9.1 ± 0.8

9.0 ± 0.6

8.9 ± 0.8

  1. Values with no asterisk have no statistically significant difference when compared with other three values in the same row using Student’s t-test
  2. FCM ferric carboxymaltose, FS ferrous sulfate
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us